With the help of University of Minnesota Health physicians, advances in drug development and clinical trials have established the current standard of care for patients with newly diagnosed multiple myeloma.
A new treatment regimen and modified maintenance therapy help keep the patient’s multiple myeloma in complete remission 3 years after transplant.Continue reading
Total shoulder arthroplasties have increased markedly in recent years as new joint technology and surgical approaches are allowing the procedure to become a viable option for more patients.Continue reading
Pediatric ventricular assist devices have improved the survival rate for infants and children awaiting heart transplant. The pediatric Heart Center, a leader in clinical trials, reports on their impact.Continue reading
Among older adults, heart failure remains a leading cause of hospitalization. Outpatient programs are changing that outlook and extending quality of life for those with chronic heart failure.Continue reading